Margarita Reboredo López

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

Javier Sastre, Marta Vidaurreta, Auxiliadora Gómez et al. · Clinical Colorectal Cancer · 2013 · 38 citations · Full text

Medicine, Prognostic Value, Colorectal Cancer +8

Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers

Ana Fernández Montés, Nieves Martínez Lago, Marta Covela Rúa et al. · Cancer Medicine · 2019 · 37 citations · Full text

Renal cell carcinoma: complete pathological response in a patient with gastric metastasis of renal cell carcinoma

Rosario García‐Campelo, María Quindós, Diana Dopico Vázquez et al. · Anti-Cancer Drugs · 2010 · 20 citations

Gastric Body, Gastric Fundus, Urology +13

Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study).

Rafael López‐López, Carlos Mendez‐Dorantes, Mónica Jorge Fernández et al. · PubMed · 2013 · 17 citations

Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

Ana Fernández Montés, Francisca Rivera, Nieves Martínez Lago et al. · Clinical & Translational Oncology · 2019 · 15 citations

Oncology, Cancer Management, Colorectal Cancer +7